|
Volumn 36, Issue 4, 2004, Pages 874-876
|
Induction versus noninduction therapy in kidney transplantation: Considering different PRA levels and different induction therapies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN A;
DACLIZUMAB;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE GRAFT REJECTION;
ADULT;
AGE DISTRIBUTION;
BLOOD TOXICITY;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DIALYSIS;
DRUG SENSITIZATION;
EVALUATION;
FEMALE;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HLA SYSTEM;
HUMAN;
KIDNEY FUNCTION;
KIDNEY GRAFT;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
PATIENT CODING;
PRIORITY JOURNAL;
REOPERATION;
SEX RATIO;
SURVIVAL RATE;
ADULT;
ANTILYMPHOCYTE SERUM;
DRUG ADMINISTRATION SCHEDULE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
ISOANTIBODIES;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE PERIOD;
RENAL REPLACEMENT THERAPY;
RETROSPECTIVE STUDIES;
TRANSPLANTATION CONDITIONING;
|
EID: 2942687482
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.03.084 Document Type: Conference Paper |
Times cited : (21)
|
References (15)
|